# Modafinil to Treat Fatigue in Post-Polio Syndrome

> **NCT00067496** · PHASE3 · TERMINATED · sponsor: **National Institute of Neurological Disorders and Stroke (NINDS)** · enrollment: 30 (—)

## Conditions studied

- Postpoliomyelitis Syndrome

## Interventions

- **DRUG:** Modafinil

## Key facts

- **NCT ID:** NCT00067496
- **Lead sponsor:** National Institute of Neurological Disorders and Stroke (NINDS)
- **Sponsor class:** NIH
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2003-08
- **Primary completion:** —
- **Final completion:** 2006-08
- **Target enrollment:** 30 (—)
- **Last updated:** 2008-08-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00067496

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00067496, "Modafinil to Treat Fatigue in Post-Polio Syndrome". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00067496. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
